At ConvaTec, we exist to improve the lives of the people we touch. We are committed to helping people with chronic health conditions lead the life they want – giving them more mobility, confidence and freedom. Our customers depend on our advanced technologies to help reduce potential complications of skin breakdown and infection, and they rely on our products and services to help manage their conditions every day. Meeting their needs is what motivates us and is a source of tremendous pride for our nearly 9,000 employees. Our vision is to be recognised as the most respected and successful MedTech company, worldwide. To achieve this, we drive for excellence in all that we do – anticipating and addressing our customers’ needs with advanced technologies and best-in-class products and services.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Pharma Tech

MYMD PHARMACEUTICALS ANNOUNCES ISSUANCE OF U.S. PATENT COVERING LEAD DRUG CANDIDATE MYMD-1 IN A METHOD OF EXTENDING LIFESPAN

MyMD | November 24, 2021

news image

MyMD Pharmaceuticals, Inc. a clinical stage pharmaceutical company committed to extending healthy lifespan by delaying aging, announced that the U.S. Patent and Trademark Office (USPTO) today issued U.S. Patent 11,179,382 B2, titled “Methods of Reversing Normal Aging Process and Extending Lifespan.” The allowed claims protect the use of MYMD-1 in a method designed to extend the lifespan of an individual. “This patent is a timely addition to ...

Read More

Research

ADARE PHARMA SOLUTIONS ANNOUNCES DIVESTITURE OF POSTBIOTICS PIONEER ADARE BIOME TO DSM-FIRMENICH

prnewswire | July 04, 2023

news image

Adare Pharma Solutions, a global technology-driven CDMO focused on oral dosage forms, today announced the completion of its divestiture of its Adare Biome business unit, a pioneer in the development and manufacturing of postbiotics, to dsm-firmenich, innovators in nutrition, health, and beauty. The transaction represents an enterprise value of €275 million, an estimated 2023 EV/EBITDA multiple of 18x. Tom Sellig, CEO of Adare Pharma Solutions, commented: "dsm-firmenich...

Read More

Business Insights

PCI PHARMA SERVICES SELECTS THOUGHTWORKS FOR DIGITAL PLATFORM TRANSFORMATION WITH AGILE APPROACH

Thoughtworks | July 11, 2022

news image

Thoughtworks a global technology consultancy that integrates strategy, design and engineering to drive digital innovation, today announced the signing of a multi-year agreement with PCI Pharma Services, a leading global contract development and manufacturing organization. Thoughtworks will help PCI in its journey to digitize its supply chain, with the goal of accelerating the time it takes to bring clients’ life-changing therapies to market for patients. By co-developing too...

Read More

Pharma Tech

THE IMA GROUP ANNOUNCES ACQUISITION OF REDLINK, INC., A SOCIAL SECURITY DISABILITY EVALUATION COMPANY

IMA Group | January 27, 2022

news image

Extending its service area to seven new states and strengthening it in seven existing markets, The IMA Group (IMA) announced today the acquisition of Redlink, Inc., a regional provider of Social Security Disability evaluations currently operating in the Western United States. The acquisition continues IMA’s long-standing commitment to providing quality Social Security Disability Consultative Examinations (CEs) and positions it to further expand its portfolio of service offerings in rapidly...

Read More
news image

Pharma Tech

MYMD PHARMACEUTICALS ANNOUNCES ISSUANCE OF U.S. PATENT COVERING LEAD DRUG CANDIDATE MYMD-1 IN A METHOD OF EXTENDING LIFESPAN

MyMD | November 24, 2021

MyMD Pharmaceuticals, Inc. a clinical stage pharmaceutical company committed to extending healthy lifespan by delaying aging, announced that the U.S. Patent and Trademark Office (USPTO) today issued U.S. Patent 11,179,382 B2, titled “Methods of Reversing Normal Aging Process and Extending Lifespan.” The allowed claims protect the use of MYMD-1 in a method designed to extend the lifespan of an individual. “This patent is a timely addition to ...

Read More
news image

Research

ADARE PHARMA SOLUTIONS ANNOUNCES DIVESTITURE OF POSTBIOTICS PIONEER ADARE BIOME TO DSM-FIRMENICH

prnewswire | July 04, 2023

Adare Pharma Solutions, a global technology-driven CDMO focused on oral dosage forms, today announced the completion of its divestiture of its Adare Biome business unit, a pioneer in the development and manufacturing of postbiotics, to dsm-firmenich, innovators in nutrition, health, and beauty. The transaction represents an enterprise value of €275 million, an estimated 2023 EV/EBITDA multiple of 18x. Tom Sellig, CEO of Adare Pharma Solutions, commented: "dsm-firmenich...

Read More
news image

Business Insights

PCI PHARMA SERVICES SELECTS THOUGHTWORKS FOR DIGITAL PLATFORM TRANSFORMATION WITH AGILE APPROACH

Thoughtworks | July 11, 2022

Thoughtworks a global technology consultancy that integrates strategy, design and engineering to drive digital innovation, today announced the signing of a multi-year agreement with PCI Pharma Services, a leading global contract development and manufacturing organization. Thoughtworks will help PCI in its journey to digitize its supply chain, with the goal of accelerating the time it takes to bring clients’ life-changing therapies to market for patients. By co-developing too...

Read More
news image

Pharma Tech

THE IMA GROUP ANNOUNCES ACQUISITION OF REDLINK, INC., A SOCIAL SECURITY DISABILITY EVALUATION COMPANY

IMA Group | January 27, 2022

Extending its service area to seven new states and strengthening it in seven existing markets, The IMA Group (IMA) announced today the acquisition of Redlink, Inc., a regional provider of Social Security Disability evaluations currently operating in the Western United States. The acquisition continues IMA’s long-standing commitment to providing quality Social Security Disability Consultative Examinations (CEs) and positions it to further expand its portfolio of service offerings in rapidly...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us